<DOC>
	<DOCNO>NCT00703534</DOCNO>
	<brief_summary>This research study do gather information clinical study use AZD3355 add-on treatment proton pump inhibitor ( PPI ) .</brief_summary>
	<brief_title>Validation Patient-reported Outcomes Measures Assessment Gastroesophageal Reflux Disease ( GERD ) Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Heartburn</mesh_term>
	<mesh_term>Lesogaberan</mesh_term>
	<criteria>Subject able read write US english able use electronic device Subjects experience GERD symptom least six month Subjects currently take prescription overthecounter PPI medication GERD Body Mass Index ( BMI ) 18.535.0 , inclusive Subjects experience GERD symptom improvement PPI treatment Subjects follow condition disease Heart disease , Angina , Seizure disorder epilepsy , Congestive Heart Failure ( CHF ) , Liver disease Cirrhosis Hepatitis , Kidney disease , Lung disease lung cancer , Cancer Prior surgery upper Gastrointestinal ( GI ) tract</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>GERD</keyword>
	<keyword>Acid Reflux</keyword>
	<keyword>Heartburn</keyword>
	<keyword>Regurgitation</keyword>
	<keyword>non-acid reflux</keyword>
	<keyword>PRO measure</keyword>
</DOC>